The Challenges of First-in-Human Stem Cell Clinical Trials: What Does This Mean for Ethics and Institutional Review Boards?
- DOI
- 10.1016/j.stemcr.2018.04.010
- Published
- 2018 May 8
- Container
- Stem cell reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.stemcr.2018.04.010,
title = {The Challenges of First-in-Human Stem Cell Clinical Trials: What Does This Mean for Ethics and Institutional Review Boards?},
author = {Barker RA and Carpenter MK and Forbes S and Goldman SA and Jamieson C and Murry CE and Takahashi J and Weir G},
year = {2018},
journal = {Stem cell reports},
doi = {10.1016/j.stemcr.2018.04.010},
url = {https://doi.org/10.1016/j.stemcr.2018.04.010}
}RIS
TY - JOUR TI - The Challenges of First-in-Human Stem Cell Clinical Trials: What Does This Mean for Ethics and Institutional Review Boards? AU - Barker RA AU - Carpenter MK AU - Forbes S AU - Goldman SA AU - Jamieson C AU - Murry CE AU - Takahashi J AU - Weir G PY - 2018 JO - Stem cell reports DO - 10.1016/j.stemcr.2018.04.010 UR - https://doi.org/10.1016/j.stemcr.2018.04.010 ER -
APA
RA, B., MK, C., S, F., SA, G., C, J., CE, M., J, T., & G, W. (2018). The Challenges of First-in-Human Stem Cell Clinical Trials: What Does This Mean for Ethics and Institutional Review Boards?. Stem cell reports. https://doi.org/10.1016/j.stemcr.2018.04.010
Source records
- pubmed · retrieved 2026-09-27T13:34:01.605Z